Eletriptan
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00216 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | migraine with brainstem aura | KG + DL |
| 2 | atrophoderma vermiculata | KG + DL |
| 3 | ulerythema ophryogenesis | KG + DL |
| 4 | sciatic neuropathy | KG + DL |
| 5 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 6 | dysthymic disorder | KG + DL |
| 7 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 8 | hypertrichosis (disease) | KG + DL |
| 9 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 10 | headache disorder | KG + DL |
| 11 | isolated genetic hair shaft abnormality | KG + DL |
| 12 | trigeminal autonomic cephalalgia | KG + DL |
| 13 | amenorrhea (disease) | KG + DL |
| 14 | congenital hypotrichosis milia | KG + DL |
| 15 | hypotrichosis simplex of the scalp | KG + DL |
| 16 | diffuse alopecia areata | KG + DL |
| 17 | tendinitis | KG + DL |
| 18 | idiopathic granulomatous myositis | KG + DL |
| 19 | myositis fibrosa | KG + DL |
| 20 | alopecia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.